{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:20:00Z","timestamp":1781194800011,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Multisystem inflammatory syndrome in children (MIS-C) is a severe disease with an unpredictable course and a substantial risk of cardiogenic shock. Our objectives were to (a) compare MIS-C phenotypes across the COVID-19 pandemic, (b) identify features associated with intensive care need and treatment with biologic agents.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Youth aged 0\u201318 years, fulfilling the World Health Organization case definition of MIS-C, and admitted to the Alberta Children\u2019s Hospital during the first four waves of the COVID-19 pandemic (May 2020-December 2021) were included in this cohort study. Demographic, clinical, biochemical, imaging, and treatment data were captured.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fifty-seven MIS-C patients (median age 6 years, range 0\u201317) were included. Thirty patients (53%) required intensive care. Patients in the third or fourth wave (indicated as phase 2 of the pandemic) presented with higher peak ferritin (\u00b5g\/l, median (IQR)\u2009=\u20091134 (409\u20131806) vs. 370 (249\u2013629), <jats:italic>P<\/jats:italic>\u2009=\u20090.001), NT-proBNP (ng\/l, median (IQR)\u2009=\u200912,217 (3013\u201327,161) vs. 3213 (1216\u20138483), <jats:italic>P<\/jats:italic>\u2009=\u20090.02) and D-dimer (mg\/l, median (IQR)\u2009=\u20094.81 (2.24\u20135.37) vs. 2.01 (1.27\u20133.34), <jats:italic>P<\/jats:italic>\u2009=\u20090.004) levels, and higher prevalence of liver enzyme abnormalities (n(%)\u2009=\u200917 (68) vs. 11 (34), <jats:italic>P<\/jats:italic>\u2009=\u20090.02), hypoalbuminemia (n(%)\u2009=\u200924 (100) vs. 25 (81), <jats:italic>P<\/jats:italic>\u2009=\u20090.03) and thrombocytopenia (n(%) 18 (72) vs. 11 (34), <jats:italic>P<\/jats:italic>\u2009=\u20090.007) compared to patients in the first two waves (phase 1). These patients had a higher need of non-invasive\/mechanical ventilation (n(%) 4 (16) vs. 0 (0), <jats:italic>P<\/jats:italic>\u2009=\u20090.03). Unsupervised clustering analyses classified 47% of the patients in the correct wave and 74% in the correct phase of the pandemic. NT-proBNP was the only significant contributor to the need for intensive care in all applied multivariate regression models. Treatment with biologic agents was significantly associated with peak CRP (mg\/l (median, IQR\u2009=\u2009240.9 (132.9-319.4) vs. 155.8 (101.0-200.7), <jats:italic>P<\/jats:italic>\u2009=\u20090.02) and ferritin levels (\u00b5g\/l, median (IQR)\u2009=\u20091380 (509\u20131753) vs. 473 (280\u2013296)).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>MIS-C patients in a later stage of the pandemic displayed a more severe phenotype, reflecting the impact of distinct SARS-CoV-2 variants. NT-proBNP emerged as the most crucial feature associated with intensive care need, underscoring the importance of monitoring.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-023-00815-w","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T14:04:15Z","timestamp":1681308255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Distinct phenotypes of multisystem inflammatory syndrome in children: a cohort study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5503-000X","authenticated-orcid":false,"given":"Thomas","family":"Renson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils D.","family":"Forkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Amador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paivi","family":"Miettunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Dhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrike","family":"Schmeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeka","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinka","family":"Twilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Hamiwka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Benseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"issue":"January","key":"815_CR1","first-page":"497","volume":"395","author":"K Ramanathan","year":"2020","unstructured":"Ramanathan K, Antognini D, Combes A, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(January):497\u2013506.","journal-title":"Lancet"},{"issue":"January","key":"815_CR2","first-page":"19","volume":"15","author":"JF Ludvigsson","year":"2020","unstructured":"Ludvigsson JF, Wu Z, McGoogan JM, et al. Correspondence: children with Covid-19 in Pediatric Emergency Departments in Italy. JAMA. 2020;15(January):19\u201321.","journal-title":"JAMA"},{"issue":"10237","key":"815_CR3","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","volume":"395","author":"S Riphagen","year":"2020","unstructured":"Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607\u20138.","journal-title":"Lancet"},{"issue":"Supplement 3","key":"815_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1542\/peds.2021-053843DDDDD","volume":"148","author":"L Verdoni","year":"2021","unstructured":"Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Pediatrics. 2021;148(Supplement 3):74\u2013S74.","journal-title":"Pediatrics"},{"key":"815_CR5","doi-asserted-by":"crossref","unstructured":"Toubiana J, Poirault C, Corsia A et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ 2020;369:m2094.","DOI":"10.1136\/bmj.m2094"},{"issue":"7","key":"815_CR6","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s00431-021-03993-5","volume":"180","author":"L Hoste","year":"2021","unstructured":"Hoste L, Van Paemel R, Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr. 2021;180(7):2019\u201334.","journal-title":"Eur J Pediatr"},{"issue":"4","key":"815_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","volume":"383","author":"LR Feldstein","year":"2020","unstructured":"Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334\u201346.","journal-title":"N Engl J Med"},{"issue":"4","key":"815_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa2021756","volume":"383","author":"EM Dufort","year":"2020","unstructured":"Dufort EM, Koumans EH, Chow EJ, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383(4):347\u201358.","journal-title":"N Engl J Med"},{"issue":"7","key":"815_CR9","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00246-020-02391-2","volume":"41","author":"T Ramcharan","year":"2020","unstructured":"Ramcharan T, Nolan O, Lai CY, et al. Paediatric inflammatory Multisystem Syndrome: temporally Associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital. Pediatr Cardiol. 2020;41(7):1391\u2013401.","journal-title":"Pediatr Cardiol"},{"issue":"5","key":"815_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S2352-4642(21)00050-X","volume":"5","author":"JY Abrams","year":"2021","unstructured":"Abrams JY, Oster ME, Godfred-Cato SE, et al. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Lancet Child Adolesc Heal. 2021;5(5):323\u201331.","journal-title":"Lancet Child Adolesc Heal"},{"key":"815_CR11","unstructured":"World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19. 2020;1\u20133."},{"issue":"17","key":"815_CR12","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","volume":"110","author":"JW Newburger","year":"2004","unstructured":"Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110(17):2747\u201371.","journal-title":"Circulation"},{"key":"815_CR13","doi-asserted-by":"crossref","unstructured":"Lo Vercio L, Amador K, Bannister JJ et al. Supervised machine learning tools: A tutorial for clinicians.J Neural Eng2020;17(6).","DOI":"10.1088\/1741-2552\/abbff2"},{"issue":"4","key":"815_CR14","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1139\/gen-2020-0131","volume":"64","author":"SJ Maceachern","year":"2021","unstructured":"Maceachern SJ, Forkert ND. Machine learning for precision medicine. Genome. 2021;64(4):416\u201325.","journal-title":"Genome"},{"key":"815_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/BF00337288","volume":"43","author":"T Kohonen","year":"1982","unstructured":"Kohonen T. Self-organized formation of topologically correct feature maps. Biol Cybern. 1982;43:59\u201369.","journal-title":"Biol Cybern"},{"issue":"3","key":"815_CR16","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/art.39332","volume":"68","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Dav\u00ec S, et al. 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International trials Organisation collaborative initiative. Arthritis Rheumatol. 2016;68(3):566\u201376.","journal-title":"Arthritis Rheumatol"},{"key":"815_CR17","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S2665-9913(21)00139-9","volume":"3","author":"J Rodriguez-Smith","year":"2021","unstructured":"Rodriguez-Smith J, Verweyen E, Clay G, et al. Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study. Lancet Rheumatol. 2021;3:574\u201384.","journal-title":"Lancet Rheumatol"},{"key":"815_CR18","unstructured":"Rodriguez-Smith et al. Lancet Rheumatol 2021;3(8):574\u2013584."},{"key":"815_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpeds.2020.11.016","volume":"230","author":"DM Fernandes","year":"2021","unstructured":"Fernandes DM, Oliveira CR, Guerguis S, et al. Severe Acute Respiratory Syndrome Coronavirus 2 clinical syndromes and predictors of disease severity in hospitalized children and youth. J Pediatr. 2021;230:23\u201331.","journal-title":"J Pediatr"},{"issue":"March","key":"815_CR20","first-page":"1","volume":"9","author":"S Garazzino","year":"2021","unstructured":"Garazzino S, Vecchio A, Lo, Pierantoni L, et al. Epidemiology, clinical features and prognostic factors of pediatric SARS-CoV-2 infection: results from an italian multicenter study. Front Pediatr. 2021;9(March):1\u201310.","journal-title":"Front Pediatr"},{"issue":"3","key":"815_CR21","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00431-021-04306-6","volume":"181","author":"A Tagarro","year":"2022","unstructured":"Tagarro A, Cobos-Carrascosa E, Villaverde S, et al. Clinical spectrum of COVID-19 and risk factors associated with severity in spanish children. Eur J Pediatr. 2022;181(3):1105\u201315.","journal-title":"Eur J Pediatr"},{"key":"815_CR22","doi-asserted-by":"crossref","unstructured":"Bautista-Rodriguez C, Sanchez-De-Toledo J, Clark BC et al. Multisystem inflammatory syndrome in children: An international survey.Pediatrics2021;147(2).","DOI":"10.1542\/peds.2020-024554"},{"issue":"4","key":"815_CR23","doi-asserted-by":"publisher","first-page":"E137","DOI":"10.1097\/INF.0000000000003043","volume":"40","author":"K Graff","year":"2021","unstructured":"Graff K, Smith C, Silveira L, et al. Risk factors for severe COVID-19 in children. Pediatr Infect Dis J. 2021;40(4):E137\u201345.","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00815-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-023-00815-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00815-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T14:07:22Z","timestamp":1681308442000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-023-00815-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["815"],"URL":"https:\/\/doi.org\/10.1186\/s12969-023-00815-w","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"9 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the University of Calgary Conjoint Health Research Ethics Board (REB20-0480). Parent(s)\/legal guardian(s) and patients (if competent minors) provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}